This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Morning Briefing: 10 Things You Should Know

Stocks in this article: SPPIBAGOOGMWEXPRVELT

NEW YORK ( TheStreet) -- Here are 10 things you should know for Wednesday, March 13:

1. -- U.S. stock futures were suggesting a weaker start for Wall Street on Wednesday, putting in jeopardy the Dow Jones Industrial Average's eight-day winning streak.

European shares were slipping on a drop in industrial production in the U.K. while Asian stocks ended mostly lower on Wednesday. Japan's Nikkei 225 index fell 0.6% to close at 12,239.66.


2. -- The economic calendar in the U.S. Wednesday includes retail sales for February at 8:30 a.m. EST and business inventories for January at 10 a.m.


3. -- U.S. stocks on Tuesday finished mixed as investor enthusiasm ebbed following more than a week of record gains.

The Dow managed to eek out an eighth-consecutive winning session and a sixth-straight record closing high while the S&P 500 snapped its seven-day rally.

The S&P 500 ended the day down 0.24% at 1,552.48 as the Dow finished up 2.77 points, or 0.02%, to 14,450.06. The technology-heavy Nasdaq slipped 0.32% to 3,242.32.


4. -- Boeing's (BA) plan to redesign the 787 Dreamliner's lithium-ion batteries won approval Tuesday from the Federal Aviation Administration.


5. -- Spectrum Pharmaceuticals (SPPI) warned Tuesday that sales of colon cancer drug Fusilev will be $10 million to $15 million in the first quarter and $80 million to $90 million for all of 2013.

Fusilev sales came in at $44.6 million and $204 million in the fourth quarter and full year 2012, respectively. Spectrum CEO Raj Shrotriya promised investors recently more revenue growth in 2013. But Tuesday the CEO admitted first-quarter Fusilev sales will drop more than 70% sequentially, and will decline by 60% in 2013.


6. -- Google (GOOG) agreed to pay a $7 million fine to settle with 38 states an investigation into the company's interception of emails, passwords and other sensitive personal information through its Street View cars that collected data from unsecured wireless networks.


7. -- Hostess agreed on Tuesday to sell its Twinkies and Ding Dongs brands to investment firms Metropoulos & Co. and Apollo Global Management for $410 million.


8. -- Analysts on Wall Street expect Men's Wearhouse (MW) on Wednesday to report a fourth-quarter loss of 5 cents a share on revenue of $610 million.


9. -- Velti (VELT) swung to a fourth-quarter loss of more than $5 million and said it expects revenue for the full year of $255 million to $280 million, below analysts' expectations of $340 million.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs